MyAverix Finance
NS · Healthcare
Colinz Laboratories Ltd (531210)
Pharmaceuticals & Biotechnology
Colinz Laboratories Ltd (531210) is listed on NS in the Healthcare sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $172.70M, P/E ratio is 33.60, net margin is 7.2%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 531210
Colinz Laboratories Ltd (531210) — FAQ
What is Colinz Laboratories Ltd's market cap?
Colinz Laboratories Ltd (531210) has a reported market cap of $172.70M (data as of 2026-07-10).
What is 531210's P/E ratio?
The price-to-earnings (P/E) ratio for Colinz Laboratories Ltd (531210) is 33.60 (data as of 2026-07-10).
Does Colinz Laboratories Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Colinz Laboratories Ltd (531210). Check the MyAverix Finance app for the latest dividend data.
What sector is Colinz Laboratories Ltd in?
Colinz Laboratories Ltd (531210) is classified in the Healthcare sector (Pharmaceuticals & Biotechnology industry).
What exchange is 531210 listed on?
531210 is listed on NS.
What is Colinz Laboratories Ltd's net margin?
Colinz Laboratories Ltd (531210) reports a net margin of 7.2% (data as of 2026-07-10).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.